U.K. Builds New Labs to Bolster Vaccines Against Covid Variants
(Bloomberg) -- The U.K. is setting up a Covid-19 testing center aimed at speeding up the deployment of vaccines tailored to tackle new coronavirus variants.
The government will invest 29.3 million pounds ($40.6 million) in “state of the art” laboratories at the Porton Down military research facility to assess the effectiveness of existing and new vaccines against variants of concern, the Health Department said in an emailed statement.
The extra funding means scientists will be able to test 3,000 blood samples a week, up from 700 now, in order to measure the level of antibodies to Covid-19 generated by the vaccines.
Johnson Predicts Lockdown Ending June 21 as He Seeks Votes
Prime Minister Boris Johnson wants to reopen all sectors of Britain's economy from June 21, amid dramatic falls in infection rates and deaths from coronavirus in recent months.
But scientists have warned of a potential resurgence of the virus later in the year when more people are mixing indoors again. Any rise in cases makes it more likely for Covid-19 to mutate and form a new variant that could be partially resistant to vaccines, which could result in further shutdowns.
The government last week announced it had bought an extra 60 million doses of the vaccine produced by Pfizer Inc. and BioNTech SE to form part of a booster program starting in the autumn. The booster shot will be made available to people over 50 and with underlying health conditions, The Times newspaper reported Wednesday citing unidentified sources.
Covid Variants
While early evidence suggests that existing vaccines are effective against variants including those first identified in Kent, southeast England, and South Africa, the U.K. government is working with pharmaceutical companies to ensure vaccines protect against current and future mutations.
“Our vaccination program has so far saved thousands of lives, but it's vital we put in place robust support for the program for the future,” Vaccine Deployment Minister Nadhim Zahawi said in the statement.
More than 50 million Covid-19 vaccine shots have been administered in the U.K. so far, including 15.6 million second doses.
The new funding comes on top of 19.7 million pounds pledged last year for the new facilities at Porton Down, taking total investment to 49 million pounds.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.